Chemotype Iii

Chemotype III refers to cannabis plants bred for high cannabidiol (CBD) content with minimal tetrahydrocannabinol (THC), a classification system developed in European hemp breeding programs. This chemotype category typically emerges from selective breeding of fiber and dual-use cultivars, and is defined by cannabinoid ratios rather than volatile terpene profiles alone. Lineage records frequently report Chemotype III plants derived from Eastern European and Swiss hemp genetics, particularly cultivars registered in the EU Common Catalogue. The aroma associated with this chemotype often reflects the underlying terpene content of parent strains—commonly woody, herbal, or hay-like notes—rather than a distinctive signature scent. Breeders working in regulatory compliance markets prioritize Chemotype III designation for predictable cannabinoid expression and legal cultivation eligibility.

Breeders select for Chemotype III through multi-generational backcrossing to stabilize high CBD/low THC ratios while maintaining agronomic traits like yield and disease resistance. This classification is critical for developing cultivars that meet European and North American hemp regulations, making it a key breeding target in compliance-focused programs.